Search Results - "KAUR, K. J"

Absence of cancer-associated changes in human fibroblasts immortalized with telomerase by Shay, Jerry W, Morales, Carmela P, Holt, Shawn E, Ouellette, Michel, Kaur, Kiran J, Yan, Ying, Wilson, Kathleen S, White, Michael A, Wright, Woodring E

“…The ectopic expression of telomerase in normal human cells results in an extended lifespan, indicating that telomere shortening regulates the timing of…”
Get full text

Phylogenetic placement of Spermospora avenae, causal agent of red leather leaf disease of oats by Zaveri, A., Mann, R. C., Kaur, J. K., Henry, F. J., Wallwork, H., Linde, C. C., Edwards, Jacqueline

“…Spermospora avenae causes the economically important red leather leaf disease of oats, which reduces grain yield and hay quality. It was first reported in the…”
Get full text

Ral GTPases Contribute to Regulation of Cyclin D1 through Activation of NF-κB by Henry, Dale O., Moskalenko, Serge A., Kaur, Kiran J., Fu, Maofu, Pestell, Richard G., Camonis, Jacques H., White, Michael A.

“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Minimum sample size and sampling time requirements for assessment of rifampicin bioequivalence from FDC formulations by AGRAWAL, S, KAUR, K. J, SINGH, I, BHADE, S, KAUL, C. L, PANCHAGNULA, R

“…SETTING: The WHO- and IUATLD-recommended protocol for rifampicin (RMP) bioequivalence utilises 20-22 volunteers and 8 h, whereas the requirement of other…”
Get full text

Determination of rifampicin bioequivalence in a three-drug FDC by WHO and Indian protocols: effect of sampling schedule and size by AGRAWAL, S, KAUR, K. J, SINGH, I, BHADE, S. R, KAUL, C. L, PANCHAGNULA, R

“…SETTING: To promote the quality assurance of fixed-dose combination (FDC) formulations, the World Health Organization (WHO) has prepared a convenient…”
Get full text

Quality control of anti-tuberculosis fixed-dose combination formulations in the global market: an in vitro study by ASHOKRAJ, Y, AGRAWAL, S, PANCHAGNULA, T. R, VARMA, M. V. S, SINGH, I, GUNJAN, K, KAUR, K. J, BHADE, S. R, KAUL, C. L, CAUDRON, J. M, PINEL, T. J

“…OBJECTIVE: To determine the quality, and especially the dissolution properties of rifampicin, of fixed-dose combination (FDC) formulations of anti-tuberculosis…”
Get full text

Porphyrin binding to jacalin is facilitated by the inherent plasticity of the carbohydrate-binding site: novel mode of lectin-ligand interaction by Goel, M., Anuradha, P., Kaur, K. J., Maiya, B. G., Swamy, M. J., Salunke, D. M.

“…The crystal structure of the complex of meso‐tetrasulfonatophenylporphyrin (H2TPPS) with jack fruit (Artocarpus integriflora) agglutinin (jacalin) has been…”
Get full text

Establishment of a reference formulation for bioequivalence assessment of rifampicin-containing FDCs: an essential step towards improving tuberculosis treatment by ASHOKRAJ, Y, SINGH, I, KAUR, K. J, KOHLI, G, BHADE, S. R, VARMA, M. V. S, KAUL, C. L, PANCHAGNULA, R

“…SETTING: Selection of a reference product for bioequivalence studies of rifampicin (RMP) in prequalifying fixed-dose combinations (FDC) for worldwide…”
Get full text

Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulations by Agrawal, S, Singh, I, Kaur, K J, Bhade, S R, Kaul, C L, Panchagnula, R

“…Depending on the patient category, tuberculosis requires treatment with 3 to 5 drugs which means that patient's compliance to therapy may not be optimal. To…”
Get more information

Plasma pooling: utility in expediting bioequivalence assessment of rifampicin-containing fixed-dose combinations by ASHOKRAJ, Y, SINGH, I, KAUR, K. J, KOHLI, G, BHADE, S. R, VARMA, M. V. S, KAUL, C. L, PANCHAGNULA, R

“…To improve the rapidity of the registration process of rifampicin (RMP) containing fixed-dose combination (FDC) formulations, a plasma pooling methodology was…”
Get full text

Enhanced Binding of a Rationally Designed Peptide Ligand of Concanavalin A Arises from Improved Geometrical Complementarity by Jain, Deepti, Kaur, Kanwal J, Salunke, Dinakar M

“…The structural basis of affinity enhancement was addressed by analyzing the interactions between concanavalin A and the carbohydrate-mimicking peptide ligands…”
Get full text

Protein translation elongation factor-1 alpha from Trypanosoma brucei binds calmodulin by Kaur, K.J. (University of Texas Southwestern Medical School, Dallas, TX.), Rubens, L

“…The following study examines the calmodulin (CaM)branch of the calcium signal pathway in the protozoan parasite Trypanosoma brucei. To accomplish this goal, a…”
Get full text

Enzymatic transfer of a preassembled trisaccharide antigen to cell surfaces using a fucosyltransferase by SRIVASTAVA, G, KAUR, K. J, HINDSGAUL, O, PALCIC, M. M

“…The Lewis alpha (1-->3/4)-fucosyltransferase (Le-FucT) is known to fucosylate both Type I (beta Gal(1-->3) beta GlcNAc) and Type II (beta Gal(1-->4) beta…”
Get full text

Evaluation of rifampicin bioequivalence in fixed-dose combinations using the WHO/IUATLD recommended protocol by PANCHAGNULA, R, AGRAWAL, S, KAUR, K. J, SINGH, I, KAUL, C. L

“…For an accurate assessment of rifampicin bioequivalence from fixed-dose combinations (FDCs), and to reduce the time and cost constraints associated with…”
Get full text

The WHO Simplified Study Protocol in practice: investigation of combined formulations supplied by the WHO by Panchagnula, R, Kaur, K J, Singh, I, Kaul, C L

“…SETTING: The benefits of fixed-dose combination (FDC) formulations of rifampicin, isoniazid and pyrazinamide over individual formulations are well…”
Get full text

Plasma pooling to expedite bioequivalence estimation of rifampicin in fixed dose combinations by PANCHAGNULA, R, PARMAR, J, KAUR, K. J, SINGH, I, BHADE, S. R

“…Rifampicin has been found to be one of the most important antitubercular drugs; however, variable bioavailability of rifampicin in some fixed dose combinations…”
Get full text

Regulation of N-acetylglucosaminyltransferase V activity. Kinetic comparisons of parental, Rous sarcoma virus-transformed BHK, and L-phytohemagglutinin-resistant BHK cells using synthetic substrates and an inhibitory substrate analog by PALCIC, M. M, RIPKA, J, KAUR, K. J, MOHAMED SHOREIBAH, HINDSGAUL, O, PIERCE, M

“…Baby hamster kidney (BHK) cells transformed with Rous sarcoma virus, RS-BHK cells, demonstrate a 2.5-fold increase in the activity of…”
Get full text

Isolation of effector-selective Ras mutants by yeast two-hybrid screening by Kaur, K J, White, M A

“…Ras mutants displaying selective target interactions will often display partial loss of function phenotypes when expressed in cells. Thus the isolation of…”
Get more information

Evaluation of deoxygenated oligosaccharide acceptor analogs as specific inhibitors of glycosyltransferases by Hindsgaul, O, Kaur, K J, Srivastava, G, Blaszczyk-Thurin, M, Crawley, S C, Heerze, L D, Palcic, M M

“…The glycosyltransferases controlling the biosynthesis of cell-surface complex carbohydrates transfer glycosyl residues from sugar nucleotides to specific…”
Get full text

Bioequivalence of rifampicin when administered as a fixed-dose combined formulation of four drugs versus separate formulations by PANCHAGNULA, R, KAUR, K. J, SINGH, I, KAUL, C. L

“…A bioequivalence study of the antitubercular drug rifampicin in a four-drug combination (rifampicin, isoniazid, pyrazinamide and ethambutol) and separate…”
Get full text